Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 3, Issue 4, 2004, Pages 253-258

  Ionescu, Alina A ^a,b   Nixon, Lisette S ^a,b   Shale, Dennis J ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

5 Ribosyluracil; Cystic fibrosis; Fat free mass; Protein breakdown; Protein catabolism; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; PSEUDOURIDINE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BODY COMPOSITION; BODY MASS; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MALE; PREDICTION; PROTEIN DEGRADATION; URINARY EXCRETION;

ADULT; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; BODY COMPOSITION; CYSTIC FIBROSIS; DENSITOMETRY, X-RAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG DISEASES; MALE; PROSPECTIVE STUDIES; PROTEINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOURIDINE; SPUTUM;

EID: 13644255948     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2004.07.003     Document Type: Article

References (26)

1. J.S. Elborn D.J. Shale J.R. Britton Cystic fibrosis: Current survival and population estimates to the year 2000 Thorax 46 1991 881-885
2. P.B. Davis M. Drumm M.W. Konstan Cystic fibrosis Am. J. Respir. Crit. Care Med. 154 1996 1229-1256
3. S.C. Bell A.M. Bowerman L.S. Nixon I.A. Macdonald J.S. Elborn D.J. Shale Metabolic and inflammatory responses to pulmonary exacerbations in adults with cystic fibrosis Eur. J. Clin. Invest. 30 2000 553-559
4. A.M.W.J. Schols W.A. Buurman A.J.S. Brekel M.A. Dentener E.F.M. Wouters Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease Thorax 51 1996 819-824
5. A. Eid A.A. Ionescu L.S. Nixon V. Lewis-Jenkins S. Matthews T.L. Grifiths et al. Inflammatory response and body composition in COPD Am. J. Respir. Crit. Care Med. 164 2001 1414-1418
6. A.A. Ionescu L.S. Nixon P.A. Routledge D.J. Shale Protein catabolism in Cystic Fibrosis and COPD Am. J. Respir. Crit. Care Med. 167 7 2003 A918 [Abstract presented (poster) at the International Conference of the ATS, Seattle 2003]
7. A.A. Ionescu L.S. Nixon S. Luzio V. Lewis-Jenkins W.D. Evans M.D. Stone et al. Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis Am. J. Respir. Crit. Care Med. 165 2002 495-500
8. H. Bohles L. Brendel H. Forster K. Trager J. Vogt M. Georgieff The effect of human growth hormone therapy on L-(methyl-2H3)-leucine turnover and urinary pseudouridine concentration in patients with Ullrich-Turner syndrome Eur. J. Pediatr. 155 1996 275-280
9. G. Sander J. Hulsemann H. Topp Protein and RNA turnover in preterm infants and adults: A comparison based on urinary excretion of 3-methylhistidine and of modified one-way RNA catabolites Ann. Nutr. Metab. 30 1986 137-142
10. J.Y. Lu R.S. Lai L.L. Liang H.C. Wang T.I. Lin Evaluation of urinary pseudouridine as a tumour marker in lung cancer J. Formos. Med. Assoc. 93 1994 25-29
11. J.G. Tebib C. Reynaud J.P. Cedoz M.C. Letroublon A. Niveleau Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process Br. J. Rheumatol. 36 1997 990-995
12. M. Intrieri G. Calcagno G. Oriani F. Pane F. Zarilli P.T. Cataldo et al. Pseudouridine and 1-ribosylpyridin-4-one-3-carboxamide serum concentrations in human immunodeficiency virus type 1-infected patients are independent predictors for AIDS progression J. Infect. Dis. 174 1996 199-203
13. K. Itoh S. Aida S. Ishiwata S. Sasaki N. Ishida M. Mizugaki Urinary excretion patterns of modified nucleosides, pseudouridine and 1-methyladenosine in healthy individuals Clin. Chim. Acta 217 1993 221-223
14. W.E. Mitch Insights into the abnormalities of chronic renal disease attributed to malnutrition J. Am. Soc. Nephrol. 13 2002 S22-S27
15. T. Tsujinaka J. Fujita C. Ebisui M. Yano E. Kominami K. Suzuki K. Tanaka A. Katsume Y. Ohsugi H. Shiozaki M. Monden Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice J. Clin. Invest. 197 1996 244-249
16. H.F. Starnes Jr R.S. Warren M. Jeevanandam J.L. Gabrilove W. Larchian H.F. Oettgen et al. Tumour necrosis factor and the acute metabolic response to tissue injury in man J. Clin. Invest. 82 1988 1321-1325
17. C.L. Kien W.B. Zipf C.A. Horswill S.C. Denne K.S. McCoy T.M. O'Dorisio Effects of feeding on protein turnover in healthy children and in children with cystic fibrosis Am. J. Clin. Nutr. 64 1996 608-614
18. R.W. Shepherd T.L. Holt L.P. Johnson P. Quirk B.J. Thomas Leucine metabolism and body cell mass in cystic fibrosis Nutrition 11 1995 138-141
19. Y. Li S. Wang N. Zhong Simultaneous determination of Pseudouridine and creatinine in urine of normal children and patients with leukaemia by HPLC Chromatography 6 1992 191-193
20. C.W. Gehrke K.C. Kuo T.P. Waalkes E. Borek Patterns of urinary excretion of modified nucleosides Cancer Res. 39 1979 1150-1153
21. L.S. Nixon B. Yung S.C. Bell J.S. Elborn D.J. Shale Circulating immunoreactive Interleukin-6 in cystic fibrosis Am. J. Respir. Crit. Care Med. 157 1998 1764-1769
22. A.A. Ionescu L.S. Nixon W.D. Evans M.D. Stone V. Lewis-Jenkins K. Chatman D.J. Shale Bone density, body composition and inflammatory status in Cystic Fibrosis Am. J. Respir. Crit. Care Med. 162 2000 789-794
23. R.M. Aris J.B. Renner A.D. Winders H.E. Buell D.B. Riggs G.E. Lester D.A. Ontjes Increased rate of fractures and severe kyphosis; sequelae of living into adulthood with cystic fibrosis Ann. Intern. Med. 128 1998 186-193
24. E.M. Pouw A.M. Schols N.E. Deutz E.F. Wouters Plasma and muscle amino acid levels in relation to REE and inflammation in stable COPD Am. J. Respir. Crit. Care Med. 158 1998 797-801
25. S.C. Bell M.J. Saunders J.S. Elborn D.J. Shale REE and oxygen cost of breathing in patients with cystic fibrosis Thorax 51 1996 126-131
26. J.S. Elborn S.M. Cordon P. Western I.A. Macdonald D.J. Shale TNFα, resting energy expenditure and cachexia in cystic fibrosis Clin. Sci. 85 1993 563-568